Patents by Inventor Richard A. Weltzin

Richard A. Weltzin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccinia virus strains
    Patent number: 7645456
    Abstract: The invention provides attenuated vaccinia virus vaccines that can be used in methods to prevent or treat small pox in patients, as well as methods of obtaining such vaccines.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: January 12, 2010
    Assignee: Sanofi Pasteur Biologics Co.
    Inventors: Richard A. Weltzin, Thomas P. Monath
  • Vaccinia Virus Strains
    Publication number: 20090324548
    Abstract: The invention provides attenuated vaccinia virus vaccines that can be used in methods to prevent or treat small pox in patients, as well as methods of obtaining such vaccines.
    Type: Application
    Filed: January 15, 2009
    Publication date: December 31, 2009
    Inventors: Richard A. Weltzin, Thomas P. Monath
  • VACCINIA VIRUS STRAINS
    Publication number: 20090169512
    Abstract: The invention provides attenuated vaccinia virus vaccines that can be used in methods to prevent or treat small pox in patients, as well as methods of obtaining such vaccines.
    Type: Application
    Filed: April 16, 2004
    Publication date: July 2, 2009
    Inventors: Richard A. Weltzin, Thomas P. Monath
  • Smallpox vaccine
    Patent number: 7115270
    Abstract: The invention provides attenuated vaccinia virus vaccines that can be used in methods to prevent or treat small pox in patients, as well as methods of obtaining such vaccines.
    Type: Grant
    Filed: May 27, 2003
    Date of Patent: October 3, 2006
    Assignee: Acambis Inc.
    Inventors: Richard A. Weltzin, Thomas P. Monath
  • SMALLPOX VACCINE
    Publication number: 20060153873
    Abstract: The invention provides attenuated vaccinia virus vaccines that can be used in methods to prevent or treat small pox in patients, as well as methods of obtaining such vaccines.
    Type: Application
    Filed: May 27, 2003
    Publication date: July 13, 2006
    Inventors: Richard Weltzin, Thomas Monath
  • Smallpox vaccine
    Patent number: 6723325
    Abstract: The invention provides attenuated vaccinia virus vaccines that can be used in methods to prevent or treat small pox in patients, as well as methods of obtaining such vaccines.
    Type: Grant
    Filed: April 23, 2001
    Date of Patent: April 20, 2004
    Assignee: Acambis, Inc.
    Inventors: Richard A. Weltzin, Thomas P. Monath
  • LT and CT in parenteral immunization methods against helicobacter infection
    Patent number: 6576244
    Abstract: This invention provides methods of inducing a protective or therapeutic immune response to Helicobacter infection in a mammal by parenterally administering to the mammal one or more Helicobacter antigens and an adjuvant selected from one or more of LT, CT, LTB, and CTB.
    Type: Grant
    Filed: June 18, 1999
    Date of Patent: June 10, 2003
    Assignee: Acambis, Inc.
    Inventors: Richard A. Weltzin, Bruno Guy
  • Multimeric, recombinant urease vaccine
    Patent number: 5837240
    Abstract: Methods and compositions are provided for prophylactic and antibacterial therapy for Helicobacter, particularly for Helicobacter pylori, infection of humans. The immunogenic composition of the invention is composed of a plurality of multimeric complexes, each complex being composed of recombinant, enzymatically inactive Helicobacter pylori urease. Each multimeric complex is composed of six Urease A subunits and six Urease B subunits. Alternatively, the composition is composed of a mixture of multimeric complexes, wherein each multimeric complex in the mixture is composed of six Urease A subunits and six Urease B subunits or four Urease A subunits and four Urease B subunits.
    Type: Grant
    Filed: August 26, 1997
    Date of Patent: November 17, 1998
    Assignee: OraVax-Merieux Co.
    Inventors: Cynthia K. Lee, Thomas P. Monath, Samuel K. Ackerman, William D. Thomas, Gopalan Soman, Harold Kleanthous, Richard A. Weltzin, Jacques Pappo, Thomas Ermak, Farshad Guirakhoo, Hitesh Bhagat, Ilene Sussman
  • Monoclonal IgA antibody specific for respiratory syncytial virus, a hybridoma cell line that produces this antibody amd methods of using the antibody to diagnose RSV infection
    Patent number: 5534411
    Abstract: A new hybridoma cell line HNK20 which secretes a monoclonal IgA antibody to respiratory syncytial virus is disclosed. The antibody has diagnostic uses in respect of Respiratory Syncytial Virus.
    Type: Grant
    Filed: March 28, 1995
    Date of Patent: July 9, 1996
    Assignee: OraVax, Inc.
    Inventor: Richard A. Weltzin